Immunophenotyping of Rhesus CMV‐Specific CD8 T‐Cell Populations

A vaccine to ameliorate cytomegalovirus (CMV)‐related pathogenicity in transplantation patients is considered a top priority. A therapeutic vaccine must include components that elicit both neutralizing antibodies, and highly effective CD8 T‐cell responses. The most important translational model of v...

Descripción completa

Detalles Bibliográficos
Autores principales: Pomplun, Nicholas L., Vosler, Logan, Weisgrau, Kim L., Furlott, Jessica, Weiler, Andrea M., Abdelaal, Hadia M., Evans, David T., Watkins, David I., Matano, Tetsuro, Skinner, Pamela J., Friedrich, Thomas C., Rakasz, Eva G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855655/
https://www.ncbi.nlm.nih.gov/pubmed/32713108
http://dx.doi.org/10.1002/cyto.a.24197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855655/
https://www.ncbi.nlm.nih.gov/pubmed/32713108
http://dx.doi.org/10.1002/cyto.a.24197

Ejemplares similares